United States Nuclear Imaging Equipment Market 2031 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

The Nuclear Imaging Equipment market is growing at a high CAGR during the forecast period (2024-2031).

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/nuclear-imaging-equipment-market?sb

Key Development:

United States: Recent Industry Developments

✅ In December 2025, GE HealthCare launched its AI‐powered Revolution Apex CT scanner with enhanced dose reduction and advanced imaging precision, supported by major U.S. manufacturing investments to scale production and meet clinical diagnostic needs.

✅ In November 2025, Sirona Medical received FDA 510(k) clearance for its Sirona advanced imaging suite, enabling broader clinical use of next‐generation nuclear imaging systems in diagnostic environments nationwide.

✅ In October 2025, Sirona Medical received FDA 510(k) clearance for its advanced nuclear imaging system, marking a regulatory milestone that enables wider clinical deployment of next‐generation PET/SPECT diagnostic tools in U.S. healthcare settings.

Japan: Recent Industry Developments

✅ In November 2025, the 65th Annual Scientific Meeting of the Japanese Society of Nuclear Medicine (JSNM) was held in Kyoto, featuring exhibits and showcases of cutting‐edge PET, SPECT, and radiopharmaceutical imaging technologies driving innovation in nuclear diagnostics.

✅ In November 2025, PDRadiopharma presented models of its future radiopharmaceutical manufacturing facility planned for completion in 2028, aimed at boosting Japan's imaging isotope production capacity.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=nuclear-imaging-equipment-market

Key Players:

=> Siemens Healthcare GmbH, GE Healthcare, Philips Healthcare, Canon Medical Systems Corp, Serac Imaging Systems Ltd, Neusoft Medical Systems Co Ltd., DIGIRAD HEALTH, INC., Mediso Ltd., PerkinElmer, and MILabs B.V.

Key Segments:

By Product

Positron Emission Tomography/Computed Tomography (PET/CT) systems lead with 40% share, driven by high adoption in oncology, cardiology, and neurology diagnostics due to their combined imaging capabilities and clinical efficiency. Positron Emission Tomography (PET) systems account for 20%, supported by standalone PET imaging for metabolic and functional studies. Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) systems hold 15%, fueled by hybrid imaging advantages and increased use in nuclear medicine. Single Photon Emission Computed Tomography (SPECT) systems represent 15%, reflecting established use in cardiology and neurology imaging. PET/Magnetic Resonance Imaging (PET/MRI) systems account for 10%, driven by advanced research applications and specialized diagnostic needs.

By Application

Oncology dominates with 45% share, driven by early cancer detection, therapy monitoring, and increasing prevalence of cancer worldwide. Cardiology accounts for 25%, supported by growing cardiovascular disease burden and imaging for functional heart assessments. Neurology holds 20%, fueled by rising neurodegenerative disease prevalence and advanced brain imaging requirements. Other applications represent 10%, including musculoskeletal disorders, inflammatory diseases, and research-focused imaging.

By End-Users

Hospitals lead with 50% share, driven by large-scale imaging infrastructure, diagnostic demand, and integrated clinical workflows. Imaging centers account for 25%, supported by specialized diagnostic services and outpatient imaging demand. Academic & research centers hold 15%, fueled by clinical research, drug development, and experimental imaging studies. Other end-users represent 10%, including government health agencies, private clinics, and corporate research facilities.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/nuclear-imaging-equipment-market?sb

By Region

North America - 35% Share
North America leads with 35%, driven by advanced healthcare infrastructure, high adoption of nuclear imaging technologies, and strong investment in hospitals and imaging centers in the U.S. and Canada.

Europe - 25% Share
Europe holds 25%, supported by high healthcare expenditure, oncology-focused imaging demand, and presence of key medical device manufacturers in Germany, France, U.K., Italy, Spain, and neighboring regions.

Asia Pacific - 25% Share
Asia Pacific accounts for 25%, fueled by expanding healthcare infrastructure, rising cancer and cardiovascular cases, and increasing nuclear imaging adoption in China, India, Japan, and Southeast Asia.

Latin America - 7% Share
Latin America holds 7%, driven by improving hospital networks, diagnostic imaging investments, and growing awareness in Brazil, Mexico, and surrounding countries.

Middle East & Africa - 8% Share
The Middle East & Africa represent 8%, supported by healthcare modernization, oncology-focused imaging adoption, and increasing private hospital expansions in GCC countries, South Africa, and other emerging markets.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.